Human microglia clear intraneuronal α-synuclein aggregates by GPNMB-mediated trogocytosis
Human microglia can erase Parkinson’s‑linked protein clumps via GPNMB, doubling mouse lifespan and rescuing dopamine neurons.
18 trends tracked about this subject — the full history, oldest to newest below.
Human microglia can erase Parkinson’s‑linked protein clumps via GPNMB, doubling mouse lifespan and rescuing dopamine neurons.
5 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Recent breakthroughs in immunology and new pharmaceutical frontiers are shifting the approach to treating Alzheimer's disease.
Researchers from SKKU have identified T-cells and bone marrow disruptions as external drivers of Alzheimer's, suggesting new ways to limit neurodegeneration.
Recent brain research offers new hope for detecting C.T.E. in living patients, addressing a major medical hurdle.
7 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
New blood-based biological age testing may allow for organ-specific health scores to predict disease risk years in advance.
New research from UW–Madison and PUCMM explores how the gut microbiota may be a target for reducing the risk of Alzheimer's and cognitive decline.
3 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
3 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
New research reveals that Tau protein can infiltrate the energy factories of brain cells, causing significant cellular disruption.
New research explores two distinct methods for clearing toxic Alzheimer's proteins from the brain: high-dose CO2 inhalation and copper-based drugs.
A rare autopsy study reveals that Alzheimer's amyloid-clearing drugs may only be effective in specific regions of the human brain.
New research identifies a link between long-term iron accumulation in the brain and the loss of neuronal resilience.
Scientists at Baylor College of Medicine have identified a tubulin protein that prevents the toxic protein clumping associated with Alzheimer's and Parkinson's.
New research into canine aging is drawing parallels between dogs and humans, prompting interest in life-extending drug trials.
Mouse studies reveal two repurposed drugs may reverse Alzheimer’s brain damage—sparking global scientific buzz
A widely used joint supplement may be accelerating Alzheimer’s progression, according to new research.